Long-term low-dose antibiotics in recalcitrant chronic rhinosinusitis: A retrospective analysis

Rhinology

Volumn 50, Issue 1, 2012, Pages 45-55

  Videler, W J M ^a   van Hee, K ^a   Reinartz, S M ^a   Georgalas, C ^a   van der Meulen, F W ^a   Fokkens, W J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antibiotic treatment; Chronic rhinosinusitis; Long term low dose; Oral administration; Retrospective

Indexed keywords

ANTIINFECTIVE AGENT; COTRIMOXAZOLE; MACROLIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; RHINITIS; SINUSITIS;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHRONIC DISEASE; FEMALE; HUMANS; MACROLIDES; MALE; MIDDLE AGED; RHINITIS; SINUSITIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

EID: 84862638868     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: 10.4193/Rhino11.123     Document Type: Article

References (68)

1. Levine HL. Functional endoscopic sinus surgery: evaluation, surgery, and follow-up of 250 patients. Laryngoscope. 1990; 100: 79-84.
2. Vleming M, Middelweerd MJ, de Vries N. Good results of endoscopic paranasal sinus surgery for chronic or recurrent sinusitis and for nasal polyps. Ned Tijdschr Geneeskd. 1993; 137: 1453-1456.
3. Matthews BL, Smith LE, Jones R, Miller C, Brookschmidt JK. Endoscopic sinus surgery: outcome in 155 cases. Otolaryngol Head Neck Surg. 1991; 104: 244-246.
4. Gliklich RE, Metson R. Effect of sinus surgery on quality of life. Otolaryngol Head Neck Surg. 1997; 117: 12-17.
5. Harkness P, Brown P, Fowler S, Topham J. A national audit of sinus surgery. Results of the Royal College of Surgeons of England comparative audit of ENT surgery. Clin Otolaryngol Allied Sci. 1997; 22: 147-151.
6. Senior BA, Kennedy DW, Tanabodee J, Kroger H, Hassab M, Lanza D. Long-term results of functional endoscopic sinus surgery. Laryngoscope. 1998; 108: 151-157.
7. Chiu AG, Palmer JN, Woodworth BA, et al. Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol. 2008; 22: 34-37.
8. Hansen FS, Djupesland PG, Fokkens WJ. Preliminary efficacy of fluticasone delivered by a novel device in recalcitrant chronic rhinosinusitis. Rhinology. 2010; 48: 292-299.
9. Ragab SM, Lund VJ, Scadding G, Saleh HA, Khalifa MA. Impact of chronic rhinosinusitis therapy on quality of life: a prospective randomized controlled trial. Rhinology. 2010; 48: 305-311.
10. Proimos E, Papadakis CE, Chimona TS, Kiagiadaki D, Ferekidis E, Yiotakis J. The effect of functional endoscopic sinus surgery on patients with asthma and CRS with nasal polyps. Rhinology. 2010; 48: 331-338.
11. Videler WJ, van Drunen CM, van der Meulen FW, Fokkens WJ. Radical surgery: effect on quality of life and pain in chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2007; 136: 261-267.
12. Videler WJ, Wreesmann VB, van der Meulen FW, Knegt PP, Fokkens WJ. Repetitive endoscopic sinus surgery failure: a role for radical surgery? Otolaryngol Head Neck Surg. 2006; 134: 586-591.
13. Wreesmann VB, Fokkens WJ, Knegt PP. Refractory chronic sinusitis: evaluation of symptom improvement after Denker's procedure. Otolaryngol Head Neck Surg. 2001; 125: 495-500.
14. Weber R, Draf W, Kratzsch B, Hosemann W, Schaefer SD. Modern concepts of frontal sinus surgery. Laryngoscope. 2001; 111: 137-146.
15. Weber R, Draf W, Keerl R, Behm K, Schick B. Long-term results of endonasal frontal sinus surgery. HNO. 1996; 44: 503-509.
16. Draf W, Weber R, Keerl R, Constantinidis J. Current aspects of frontal sinus surgery. I: Endonasal frontal sinus drainage in inflammatory diseases of the paranasal sinuses. HNO. 1995; 43: 352-357.
17. Proctor RA. Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008; 46: 584-593
18. Zander J, Besier S, Ackermann H, Wichelhaus TA. Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs. Antimicrob Agents Chemother 2010; 54: 1226-1231
19. Omura S. Macrolide antibiotics: chemistry, biology and practice. Amsterdam; Boston: Academic Press;
20. Tamaoki J. The effects of macrolides on inflammatory cells. Chest. 2004; 125: 41S-50S; quiz 51S.
21. Masters PA, O'Bryan TA, Zurlo J, Miller DQ, Joshi N. Trimethoprim-sulfamethoxazole revisited. Arch Intern Med. 2003; 163: 402-410.
22. Cunha BA. New uses for older antibiotics. The 'rediscovery' of four beneficial and cost-effective antimicrobials. Postgrad Med. 1997; 101: 68-70, 73-4, 79-80.
23. J Mermin, JR Lule, JP Ekwaru, C Pitter, Should cotrimoxazole prophylaxis be taken by all adults with HIV in Africa? AIDS. 2005;19: 845-846.
24. Cervin A, Kalm O, Sandkull P, Lindberg S. One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg. 2002; 126: 481-489.
25. Suzuki H, Shimomura A, Ikeda K, Oshima T, Takasaka T. Effects of long-term low-dose macrolide administration on neutrophil recruitment and IL-8 in the nasal discharge of chronic sinusitis patients. Tohoku J Exp Med. 1997; 182: 115-124.
26. Ichimura K, Shimazaki Y, Ishibashi T, Higo R. Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx. 1996; 23: 48-56.
27. Hashiba M, Baba S. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol Suppl. 996; 525: 73-78.
28. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope. 2004; 114: 923-930.
29. Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope. 2006; 116: 189-193.
30. van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, et al. Oral steroids and doxy-cycline: Two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010; 125: 1069-1076.
31. Fokkens W, Lund V, Mullol J, European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl. 2007: 1-136.
32. Marchisio P, Principi N, Sala E, Lanzoni L, Sorella S, Massimini A. Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children. Antimicrob Agents Chemother. 1996; 40: 2732-2736.
33. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother. 1990; 25 Suppl A: 73-82.
34. Nahata MC, Koranyi KI, Luke DR, Foulds G. Pharmacokinetics of azithromycin in pediatric patients with acute otitis media. Antimicrob Agents Chemother. 1995; 39: 1875-1877.
35. Pukander J, Rautianen M. Penetration of azithromycin into middle ear effusions in acute and secretory otitis media in children. J Antimicrob Chemother. 1996; 37 Suppl C: 53-61.
36. Rott O, Mignon-Godefroy K, Fleischer B, Charreire J, Cash E. Superantigens induce primary T cell responses to soluble autoantigens by a non-V beta-specific mechanism of bystander activation. Cell Immunol. 1995; 161: 158-165.
37. Gevaert P, Holtappels G, Johansson SG, Cuvelier C, Cauwenberge P, Bachert C. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy. 2005; 60: 71-79.
38. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001; 107: 607-614.
39. Zhang N, Gevaert P, van Zele T, et al. An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis. Rhinology. 2005; 43: 162-168.
40. Seiberling KA, Grammer L, Kern RC. Chronic rhinosinusitis and superantigens. Otolaryngol Clin North Am. 2005; 38: 1215-1236.
41. Davis LJ, Kita H. Pathogenesis of chronic rhinosinusitis: role of airborne fungi and bacteria. Immunol Allergy Clin North Am. 2004; 24: 59-73.
42. Braun H, Buzina W, Freudenschuss K, Beham A, Stammberger H. 'Eosinophilic fungal rhinosinusitis': a common disorder in Europe? Laryngoscope. 2003; 113: 264-269.
43. Shin SH, Ponikau JU, Sherris DA, et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol. 2004; 114: 1369-1375.
44. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. 1999; 74: 877-884.
45. Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol. 2005; 115: 125-131.
46. Khalid AN, Hunt J, Perloff JR, Kennedy DW. The role of bone in chronic rhinosinusitis. Laryngoscope. 2002; 112: 1951-1957.
47. Lee JT, Kennedy DW, Palmer JN, Feldman M, Chiu AG. The incidence of concurrent osteitis in patients with chronic rhinosinusitis: a clinicopathological study. Am J Rhinol. 2006; 20: 278-282.
48. Kennedy DW, Senior BA, Gannon FH, Montone KT, Hwang P, Lanza DC. Histology and histomorphometry of ethmoid bone in chronic rhinosinusitis. Laryngoscope. 1998; 108: 502-507.
49. Perloff JR, Gannon FH, Bolger WE, Montone KT, Orlandi R, Kennedy DW. Bone involvement in sinusitis: an apparent pathway for the spread of disease. Laryngoscope. 2000; 110: 2095-2099.
50. Post JC, Stoodley P, Hall-Stoodley L, Ehrlich GD. The role of biofilms in otolaryngologic infections. Curr Opin Otolaryngol Head Neck Surg. 2004; 12: 185-190.
51. Clement S, Vaudaux P, Francois P, et al. Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis. 2005; 192: 1023-1028.
52. Plouin-Gaudon I, Clement S, Huggler E, et al. Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis. Rhinology. 2006; 44: 249-254.
53. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of egener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med. 1996; 335: 16-20.
54. Liese J, Kloos S, Jendrossek V, et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr. 2000; 137: 687-693.
55. Hughes WT, Dankner WM, Yogev R, et al. Comparison of atovaquone and azithromy-cin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection. Clin Infect Dis. 2005; 40: 136-145.
56. Aukema AA, Fokkens WJ. Chronic rhinosinusitis: management for optimal outcomes. Treat Respir Med. 2004; 3: 97-105.
57. Nonaka M, Pawankar R, Saji F, Yagi T. Effect of roxithromycin on IL-8 synthesis and proliferation of nasal polyp fibroblasts. Acta Otolaryngol Suppl. 1998; 539: 71-75.
58. Kohyama T, Takizawa H, Kawasaki S, Akiyama N, Sato M, Ito K. Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. Antimicrob Agents Chemother. 1999; 43: 907-911.
59. Miyanohara T, Ushikai M, Matsune S, Ueno K, Katahira S, Kurono Y. Effects of clarithromy-cin on cultured human nasal epithelial cells and fibroblasts. Laryngoscope. 2000; 110: 126-131.
60. Cervin A. The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. Acta Otolaryngol. 2001; 121: 83-92.
61. Scadding GK, Lund VJ, Darby YC. The effect of long-term antibiotic therapy upon ciliary beat frequency in chronic rhinosinusitis. J Laryngol Otol. 1995; 109: 24-26.
62. Sofer D, Gilboa-Garber N, Belz A, Garber NC. 'Subinhibitory' erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. Chemotherapy. 1999; 45: 335-341.
63. Rozin A, Schapira D, Braun-Moscovici Y, Nahir AM. Cotrimoxazole treatment for rheumatoid arthritis. Semin Arthritis Rheum. 2001; 31: 133-141.
64. Briggs RD, Wright ST, Cordes S, Calhoun KH. Smoking in chronic rhinosinusitis: a predictor of poor long-term outcome after endoscopic sinus surgery. Laryngoscope. 2004; 114: 126-128.
65. Storms W. Clinical trials: are these your patients? J Allergy Clin Immunol. 2003; 112: S107-S111.
66. Falagas ME, Vouloumanou EK, Sgouros K, Athanasiou S, Peppas G, Siempos II. Patients included in randomised controlled trials do not represent those seen in clinical practice: focus on antimicrobial agents. Int J Antimicrob Agents. 2010; 36: 1-13.
67. Kalata P, Martus P, Zettl H, et al. Differences between clinical trial participants and patients in a population-based registry: the German Rectal Cancer Study vs. the Rostock Cancer Registry. Dis Colon Rectum. 2009; 52: 425-437.
68. Suzuki H, Ikeda K, Honma R, et al. Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. ORL J Otorhinolaryngol Relat Spec. 2000; 62: 121-127.